Mr. Schulz is a serial entrepreneur with over 20 years of financial experience working with public accounting firms, Fortune 500 companies and small start-up companies. Jim graduated from Indiana University, Bloomington, in 1992 and worked for over seven years with Ernst & Young (E&Y). While working at E&Y, Jim supported a variety of clients specializing in manufacturing, financial services and transportation industries. After leaving E&Y, Jim worked for 5 years in various financial and operational roles with Eli Lilly and Company. Jim left Eli Lilly to pursue more entrepreneurial opportunities and began working as the Director of Finance for Suros Surgical Systems. After Suros was acquired by Hologic Inc., for $240 million, Jim focused his role in Upward Focus to support various life science companies in the medical device and pharmaceutical industries. Since 2007, Jim has helped several companies raise over $250 million in capital and was involved in the merger of Assembly Pharmaceuticals to Ventrus Biosciences, Inc. in July of 2014 and the sale of Naurex Inc. to Allergan in August 2015